Apis Capital Advisors, LLC Cyma Bay Therapeutics, Inc. Transaction History

Apis Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $472,800 - $590,400	-120,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.73 - $9.03 $687,600 - $1.08 Million	120,000 New	120,000 $689,000
Q2 2019 Aug 13, 2019	SELL	$6.05 - $13.66 $665,500 - $1.5 Million	-110,000 Closed	0 $0
Q1 2019 May 07, 2019	SELL	$8.16 - $13.42 $408,000 - $671,000	-50,000 Reduced 31.25%	110,000 $1.46 Million
Q4 2018 Feb 14, 2019	BUY	$6.54 - $11.74 $1.05 Million - $1.88 Million	160,000 New	160,000 $1.26 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Apis Capital Advisors, LLC with notifications on news.